Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
FCA Venture Partners
AddedFeb 17, 2024
UpdatedJun 28, 2026
FCA Venture Partners

FCA Venture Partners

Operating

FCA Venture Partners: Investing in fast-growing healthcare firms since 1996, enhancing patient care & industry efficiency.

Location
Brentwood, TN, US
Founded
1996
Firm
Compare
Portfolio
Employees
Website

FCA Venture Partners focuses on investing in fast-growing healthcare companies, typically deploying $3-6M per investment. The firm targets businesses that improve healthcare processes, enhance efficiency, reduce costs, and elevate patient care quality. With offices in Nashville and Winston-Salem, FCA has been active in the healthcare venture capital space since 1996.

Notable portfolio companies include SonderMind, Vivante Health, and Ideon. FCA's strategic value extends beyond capital, leveraging its deep healthcare industry expertise and connections to support portfolio companies. The firm's roots with Clayton Associates and the McWhorter Family contribute to its strong network in the healthcare sector, providing additional resources to its investments.

FCA Venture Partners - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments42
Current Portfolio Count27
Total Portfolio Exits2

Top Investment Stages

Series A21 (52.5%)
Series B7 (17.5%)
Series Unknown6 (15.0%)
Convertible Note3 (7.5%)
Seed3 (7.5%)

Stage Mix

Series A 53%Series B 18%Series Unknown 15%Convertible Note 8%Seed 8%

Concentration shown as share of disclosed investments by stage.

Recent Investments

BranchLab logo

BranchLab

Credo logo

Credo

PayGround logo

PayGround

EvolvedMD logo

EvolvedMD

Diligent Pharma logo

Diligent Pharma

Intrinsic logo

Intrinsic

Carallel logo

Carallel

Impiricus logo

Impiricus

Vivante Health logo

Vivante Health

OhMD logo

OhMD

Enable Dental logo

Enable Dental

Virgo logo

Virgo

GoCheck logo

GoCheck

SonderMind logo

SonderMind

Spiras Health logo

Spiras Health

Feedtrail logo

Feedtrail

Ideon logo

Ideon

eBlu Solutions logo

eBlu Solutions

SafeRide logo

SafeRide

Remedly logo

Remedly

StudioNow logo

StudioNow

MediQuire logo

MediQuire

Kerafast logo

Kerafast

LogoGarden logo

LogoGarden

ProviderTrust logo

ProviderTrust

FCA Venture Partners - Classification

NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end